

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vascular endothelial growth factor signaling pathway (GO:0038084) | 6.59213711 |
| 2 | acylglycerol catabolic process (GO:0046464) | 6.16370224 |
| 3 | neutral lipid catabolic process (GO:0046461) | 6.16370224 |
| 4 | lymph vessel development (GO:0001945) | 6.03045638 |
| 5 | regulation of sequestering of triglyceride (GO:0010889) | 5.93404346 |
| 6 | fatty acid transmembrane transport (GO:1902001) | 5.75186920 |
| 7 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.54370500 |
| 8 | transcytosis (GO:0045056) | 4.86281560 |
| 9 | carnitine shuttle (GO:0006853) | 4.82813942 |
| 10 | response to dietary excess (GO:0002021) | 4.79761972 |
| 11 | glycerolipid catabolic process (GO:0046503) | 4.73026815 |
| 12 | endothelium development (GO:0003158) | 4.70408383 |
| 13 | lipid particle organization (GO:0034389) | 4.65479439 |
| 14 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.64493316 |
| 15 | low-density lipoprotein particle clearance (GO:0034383) | 4.62260455 |
| 16 | cardiac myofibril assembly (GO:0055003) | 4.60281517 |
| 17 | positive regulation of glomerulus development (GO:0090193) | 4.30747687 |
| 18 | brown fat cell differentiation (GO:0050873) | 4.29201034 |
| 19 | sprouting angiogenesis (GO:0002040) | 4.28867614 |
| 20 | tricarboxylic acid cycle (GO:0006099) | 4.25480613 |
| 21 | venous blood vessel morphogenesis (GO:0048845) | 4.22944225 |
| 22 | sarcomere organization (GO:0045214) | 4.19001225 |
| 23 | myofibril assembly (GO:0030239) | 4.14097219 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 4.07642521 |
| 25 | positive regulation of protein kinase C signaling (GO:0090037) | 3.99749714 |
| 26 | polyol transport (GO:0015791) | 3.97829411 |
| 27 | ethanol oxidation (GO:0006069) | 3.93378704 |
| 28 | negative regulation of response to food (GO:0032096) | 3.89896613 |
| 29 | negative regulation of appetite (GO:0032099) | 3.89896613 |
| 30 | regulation of actin filament-based movement (GO:1903115) | 3.88208261 |
| 31 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.87688291 |
| 32 | heart trabecula formation (GO:0060347) | 3.85285488 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.84723600 |
| 34 | ovulation from ovarian follicle (GO:0001542) | 3.83901085 |
| 35 | biotin metabolic process (GO:0006768) | 3.80641810 |
| 36 | fatty acid beta-oxidation (GO:0006635) | 3.80258754 |
| 37 | fatty acid homeostasis (GO:0055089) | 3.79373228 |
| 38 | carnitine transmembrane transport (GO:1902603) | 3.78850542 |
| 39 | glomerular filtration (GO:0003094) | 3.78427009 |
| 40 | surfactant homeostasis (GO:0043129) | 3.78245026 |
| 41 | positive regulation of glycolytic process (GO:0045821) | 3.78010060 |
| 42 | negative regulation of macrophage differentiation (GO:0045650) | 3.76078988 |
| 43 | regulation of sarcomere organization (GO:0060297) | 3.75831321 |
| 44 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.73947809 |
| 45 | creatine metabolic process (GO:0006600) | 3.69123526 |
| 46 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.68674489 |
| 47 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.68038059 |
| 48 | regulation of lipoprotein metabolic process (GO:0050746) | 3.64813307 |
| 49 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.62905814 |
| 50 | lymphangiogenesis (GO:0001946) | 3.61344980 |
| 51 | cGMP-mediated signaling (GO:0019934) | 3.60150723 |
| 52 | valine metabolic process (GO:0006573) | 3.57454259 |
| 53 | phagocytosis, recognition (GO:0006910) | 3.54841495 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 3.52394412 |
| 55 | coronary vasculature morphogenesis (GO:0060977) | 3.50616336 |
| 56 | positive regulation of vasculogenesis (GO:2001214) | 3.49607298 |
| 57 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.45703913 |
| 58 | regulation of fatty acid oxidation (GO:0046320) | 3.42947314 |
| 59 | detection of calcium ion (GO:0005513) | 3.42533465 |
| 60 | carnitine transport (GO:0015879) | 3.42469545 |
| 61 | amino-acid betaine transport (GO:0015838) | 3.42469545 |
| 62 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.39967250 |
| 63 | adult feeding behavior (GO:0008343) | 3.39934728 |
| 64 | regulation of cholesterol storage (GO:0010885) | 3.39351644 |
| 65 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.38672667 |
| 66 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.36118319 |
| 67 | diacylglycerol metabolic process (GO:0046339) | 3.35810072 |
| 68 | cardiac muscle hypertrophy (GO:0003300) | 3.35645748 |
| 69 | response to epinephrine (GO:0071871) | 3.35569153 |
| 70 | negative regulation of amino acid transport (GO:0051956) | 3.35496732 |
| 71 | protein heterotrimerization (GO:0070208) | 3.34869058 |
| 72 | blood vessel maturation (GO:0001955) | 3.34544684 |
| 73 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.34330562 |
| 74 | potassium ion export (GO:0071435) | 3.32619906 |
| 75 | regulation of gonadotropin secretion (GO:0032276) | 3.32151612 |
| 76 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.29358611 |
| 77 | NADH metabolic process (GO:0006734) | 3.27339841 |
| 78 | oxaloacetate metabolic process (GO:0006107) | 3.27039160 |
| 79 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.26584628 |
| 80 | ganglion development (GO:0061548) | 3.26183909 |
| 81 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.25518345 |
| 82 | axon extension involved in axon guidance (GO:0048846) | 3.25518345 |
| 83 | endothelial cell morphogenesis (GO:0001886) | 3.24408579 |
| 84 | fatty acid oxidation (GO:0019395) | 3.23708212 |
| 85 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.20445334 |
| 86 | lipid oxidation (GO:0034440) | 3.20200659 |
| 87 | regulation of vasculogenesis (GO:2001212) | 3.19187826 |
| 88 | triglyceride catabolic process (GO:0019433) | 3.18742333 |
| 89 | positive regulation of lipid storage (GO:0010884) | 3.17746971 |
| 90 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.17521959 |
| 91 | triglyceride homeostasis (GO:0070328) | 3.15776934 |
| 92 | acylglycerol homeostasis (GO:0055090) | 3.15776934 |
| 93 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.15551310 |
| 94 | cardiac muscle contraction (GO:0060048) | 3.15276613 |
| 95 | positive regulation of fatty acid oxidation (GO:0046321) | 3.14764034 |
| 96 | lipid storage (GO:0019915) | 3.14623979 |
| 97 | renal filtration (GO:0097205) | 3.14054827 |
| 98 | positive regulation of vascular permeability (GO:0043117) | 3.12986489 |
| 99 | striated muscle hypertrophy (GO:0014897) | 3.12459124 |
| 100 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10774845 |
| 101 | positive regulation of macrophage cytokine production (GO:0060907) | 3.08884128 |
| 102 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.08350224 |
| 103 | glycerol metabolic process (GO:0006071) | 3.06830016 |
| 104 | fatty acid catabolic process (GO:0009062) | 3.06795061 |
| 105 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.06761897 |
| 106 | chemical homeostasis within a tissue (GO:0048875) | 3.06060413 |
| 107 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.05675684 |
| 108 | regulation of skeletal muscle contraction (GO:0014819) | 3.05449602 |
| 109 | phosphatidic acid metabolic process (GO:0046473) | 3.04231266 |
| 110 | phosphatidic acid biosynthetic process (GO:0006654) | 3.04231266 |
| 111 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.03120095 |
| 112 | negative regulation of gluconeogenesis (GO:0045721) | 3.01506595 |
| 113 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.00543750 |
| 114 | carnitine metabolic process (GO:0009437) | 2.99240367 |
| 115 | regulation of endothelial cell differentiation (GO:0045601) | 2.98688229 |
| 116 | actin-myosin filament sliding (GO:0033275) | 2.97694380 |
| 117 | muscle filament sliding (GO:0030049) | 2.97694380 |
| 118 | plasma membrane repair (GO:0001778) | 2.96872808 |
| 119 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.96701080 |
| 120 | plasma lipoprotein particle clearance (GO:0034381) | 2.96604750 |
| 121 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.96546657 |
| 122 | cellular response to leptin stimulus (GO:0044320) | 2.96116386 |
| 123 | 2-oxoglutarate metabolic process (GO:0006103) | 2.95330600 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.93920700 |
| 125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.93920700 |
| 126 | basement membrane organization (GO:0071711) | 2.93043860 |
| 127 | response to phenylpropanoid (GO:0080184) | 2.92416149 |
| 128 | branched-chain amino acid catabolic process (GO:0009083) | 2.90772893 |
| 129 | white fat cell differentiation (GO:0050872) | 2.90475084 |
| 130 | branched-chain amino acid metabolic process (GO:0009081) | 2.88966069 |
| 131 | negative regulation of granulocyte differentiation (GO:0030853) | 2.88387140 |
| 132 | ethanol metabolic process (GO:0006067) | 2.88109239 |
| 133 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.88088461 |
| 134 | regulation of coenzyme metabolic process (GO:0051196) | 2.88058867 |
| 135 | regulation of cofactor metabolic process (GO:0051193) | 2.88058867 |
| 136 | tricarboxylic acid metabolic process (GO:0072350) | 2.86817448 |
| 137 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.85414775 |
| 138 | muscle hypertrophy (GO:0014896) | 2.85270905 |
| 139 | regulation of the force of heart contraction (GO:0002026) | 2.85196531 |
| 140 | regulation of lipid storage (GO:0010883) | 2.84840224 |
| 141 | regulation of protein kinase A signaling (GO:0010738) | 2.84329992 |
| 142 | substrate-dependent cell migration (GO:0006929) | 2.84159699 |
| 143 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.83291549 |
| 144 | phenol-containing compound catabolic process (GO:0019336) | 2.82882301 |
| 145 | patterning of blood vessels (GO:0001569) | 2.81860440 |
| 146 | succinate metabolic process (GO:0006105) | 2.81647745 |
| 147 | actomyosin structure organization (GO:0031032) | 2.78652474 |
| 148 | cardiac muscle cell development (GO:0055013) | 2.77862958 |
| 149 | adrenergic receptor signaling pathway (GO:0071875) | 2.77413898 |
| 150 | cardiac cell development (GO:0055006) | 2.76880881 |
| 151 | negative regulation of endothelial cell migration (GO:0010596) | 2.76001805 |
| 152 | cellular response to epinephrine stimulus (GO:0071872) | 2.75867741 |
| 153 | positive regulation of metanephros development (GO:0072216) | 2.75537195 |
| 154 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.75415028 |
| 155 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.75403905 |
| 156 | primary alcohol metabolic process (GO:0034308) | 2.73831393 |
| 157 | regulation of glomerulus development (GO:0090192) | 2.71017141 |
| 158 | cAMP catabolic process (GO:0006198) | 2.71009343 |
| 159 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.70439130 |
| 160 | response to leptin (GO:0044321) | 2.68811428 |
| 161 | response to vitamin E (GO:0033197) | 2.68634474 |
| 162 | negative regulation of protein autophosphorylation (GO:0031953) | 2.66555430 |
| 163 | behavioral response to nicotine (GO:0035095) | 2.65636560 |
| 164 | endocrine hormone secretion (GO:0060986) | 2.63610235 |
| 165 | somite development (GO:0061053) | 2.63511696 |
| 166 | negative regulation of metanephros development (GO:0072217) | 2.63290588 |
| 167 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.62664220 |
| 168 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.59267843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.91771677 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.95924427 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.85801007 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.01114617 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.42905590 |
| 6 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.22237140 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 3.14616143 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.02148823 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.76918692 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.62982860 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.51924651 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.29925884 |
| 13 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.28865675 |
| 14 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.28865675 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06162535 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05975760 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00643836 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.98058285 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96611119 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.87756444 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81014593 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.80511819 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80405098 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76373441 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.76210191 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71218849 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.70376463 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70278119 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.70037944 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.69406187 |
| 31 | CJUN_26792858_Chip-Seq_BT549_Human | 1.65659881 |
| 32 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.62396575 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61869430 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60958351 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60550983 |
| 36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.60316827 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.59577156 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.58551213 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54465636 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54160698 |
| 41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46544099 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45834942 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45520858 |
| 44 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45509790 |
| 45 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44997538 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44725649 |
| 47 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43546664 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42539996 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42468415 |
| 50 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.42134738 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.39762556 |
| 52 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.39128994 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38051880 |
| 54 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.37544185 |
| 55 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.37544185 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36816133 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.36568892 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33441546 |
| 59 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.33312469 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.32773917 |
| 61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.31336467 |
| 62 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.30525594 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.29907703 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28123968 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27701995 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27545671 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25551251 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22906583 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21579675 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21123598 |
| 71 | ERA_21632823_ChIP-Seq_H3396_Human | 1.20047266 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19601893 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19429990 |
| 74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19381618 |
| 75 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19349715 |
| 76 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.19204516 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16522179 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16040365 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15817832 |
| 80 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.13900580 |
| 81 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.12604701 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11890017 |
| 83 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11218680 |
| 84 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.10858395 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10644482 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09254179 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09254179 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08155211 |
| 89 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.07481992 |
| 90 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.06939844 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06579834 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06067241 |
| 93 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05556403 |
| 94 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.04725257 |
| 95 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03842663 |
| 96 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03730782 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03141661 |
| 98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02170100 |
| 99 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01873074 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01640156 |
| 101 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.00895778 |
| 102 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99748223 |
| 103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99549413 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99486379 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99418435 |
| 106 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99149577 |
| 107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.98434962 |
| 108 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98101174 |
| 109 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97985053 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96715607 |
| 111 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96555156 |
| 112 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96555156 |
| 113 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.95997806 |
| 114 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95675410 |
| 115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95479923 |
| 116 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94848162 |
| 117 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94720557 |
| 118 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94131256 |
| 119 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93909410 |
| 120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93781228 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93700911 |
| 122 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93677740 |
| 123 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93500056 |
| 124 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91801232 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91692628 |
| 126 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91132977 |
| 127 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90702934 |
| 128 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.90698620 |
| 129 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90215667 |
| 130 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90215667 |
| 131 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.89870231 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.89260299 |
| 133 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88326828 |
| 134 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87954526 |
| 135 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87707731 |
| 136 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.87624841 |
| 137 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87549978 |
| 138 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86439084 |
| 139 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86327041 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86323382 |
| 141 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85139670 |
| 142 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84950076 |
| 143 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84950076 |
| 144 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.84762932 |
| 145 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.84451397 |
| 146 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84290563 |
| 147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84180936 |
| 148 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83985503 |
| 149 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.83757963 |
| 150 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83740269 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83362709 |
| 152 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82822825 |
| 153 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82263781 |
| 154 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.81682296 |
| 155 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79811814 |
| 156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79560224 |
| 157 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79450879 |
| 158 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.79447533 |
| 159 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79125532 |
| 160 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78771715 |
| 161 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.78597137 |
| 162 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.78421644 |
| 163 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.78017883 |
| 164 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.77974264 |
| 165 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.77142250 |
| 166 | P300_19829295_ChIP-Seq_ESCs_Human | 0.76970984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 4.90133004 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.42574487 |
| 3 | MP0004215_abnormal_myocardial_fiber | 4.00535379 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.98079127 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.95733872 |
| 6 | MP0001879_abnormal_lymphatic_vessel | 3.87716928 |
| 7 | MP0004130_abnormal_muscle_cell | 3.68187156 |
| 8 | MP0003828_pulmonary_edema | 3.50685833 |
| 9 | MP0003724_increased_susceptibility_to | 3.36517751 |
| 10 | MP0003646_muscle_fatigue | 2.96059299 |
| 11 | MP0004272_abnormal_basement_membrane | 2.95367103 |
| 12 | MP0000751_myopathy | 2.78582784 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.69274492 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.65034654 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.63344124 |
| 16 | MP0005330_cardiomyopathy | 2.55630817 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.36227346 |
| 18 | MP0003959_abnormal_lean_body | 2.32872855 |
| 19 | MP0006138_congestive_heart_failure | 2.32685501 |
| 20 | MP0002972_abnormal_cardiac_muscle | 2.29194711 |
| 21 | MP0004147_increased_porphyrin_level | 2.23259929 |
| 22 | MP0003011_delayed_dark_adaptation | 2.21495441 |
| 23 | MP0001544_abnormal_cardiovascular_syste | 2.17663355 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.17663355 |
| 25 | MP0000749_muscle_degeneration | 2.08229555 |
| 26 | MP0000343_altered_response_to | 2.05114042 |
| 27 | MP0004484_altered_response_of | 1.99438525 |
| 28 | MP0005620_abnormal_muscle_contractility | 1.94407723 |
| 29 | MP0010630_abnormal_cardiac_muscle | 1.91214968 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.81049838 |
| 31 | MP0005375_adipose_tissue_phenotype | 1.80714810 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.79606137 |
| 33 | MP0004087_abnormal_muscle_fiber | 1.78972460 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.76597297 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.76045666 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.75033416 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.71829658 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.71141526 |
| 39 | MP0005448_abnormal_energy_balance | 1.57521333 |
| 40 | MP0003279_aneurysm | 1.56918724 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.55553216 |
| 42 | MP0005165_increased_susceptibility_to | 1.51299092 |
| 43 | MP0004085_abnormal_heartbeat | 1.50096525 |
| 44 | MP0002108_abnormal_muscle_morphology | 1.49130708 |
| 45 | MP0005503_abnormal_tendon_morphology | 1.43194502 |
| 46 | MP0002127_abnormal_cardiovascular_syste | 1.35766604 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.33518928 |
| 48 | MP0002971_abnormal_brown_adipose | 1.33369334 |
| 49 | MP0003137_abnormal_impulse_conducting | 1.29570642 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.28449972 |
| 51 | MP0002106_abnormal_muscle_physiology | 1.28231940 |
| 52 | MP0006054_spinal_hemorrhage | 1.28154360 |
| 53 | MP0000003_abnormal_adipose_tissue | 1.26971315 |
| 54 | MP0004510_myositis | 1.25003990 |
| 55 | MP0008995_early_reproductive_senescence | 1.24197868 |
| 56 | MP0009115_abnormal_fat_cell | 1.23894608 |
| 57 | MP0009697_abnormal_copulation | 1.23774894 |
| 58 | MP0005452_abnormal_adipose_tissue | 1.20957530 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.20829792 |
| 60 | MP0001853_heart_inflammation | 1.18358828 |
| 61 | MP0000767_abnormal_smooth_muscle | 1.14488604 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.13121609 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.12586664 |
| 64 | MP0005266_abnormal_metabolism | 1.11171857 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.09728573 |
| 66 | MP0000230_abnormal_systemic_arterial | 1.02238835 |
| 67 | MP0002128_abnormal_blood_circulation | 1.00917318 |
| 68 | MP0000266_abnormal_heart_morphology | 0.98676168 |
| 69 | MP0005369_muscle_phenotype | 0.98252894 |
| 70 | MP0002295_abnormal_pulmonary_circulatio | 0.97599275 |
| 71 | MP0003045_fibrosis | 0.96782585 |
| 72 | MP0005334_abnormal_fat_pad | 0.95419802 |
| 73 | MP0010329_abnormal_lipoprotein_level | 0.95111661 |
| 74 | MP0001764_abnormal_homeostasis | 0.94282552 |
| 75 | MP0005595_abnormal_vascular_smooth | 0.94112111 |
| 76 | MP0000759_abnormal_skeletal_muscle | 0.91924631 |
| 77 | MP0005171_absent_coat_pigmentation | 0.89583077 |
| 78 | MP0001881_abnormal_mammary_gland | 0.87709922 |
| 79 | MP0005647_abnormal_sex_gland | 0.87528482 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.87468938 |
| 81 | MP0003868_abnormal_feces_composition | 0.87084443 |
| 82 | MP0005535_abnormal_body_temperature | 0.86736704 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.86546600 |
| 84 | MP0000249_abnormal_blood_vessel | 0.85126874 |
| 85 | MP0003948_abnormal_gas_homeostasis | 0.83242137 |
| 86 | MP0008438_abnormal_cutaneous_collagen | 0.83170566 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.82981125 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.82452026 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82217780 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 0.81172531 |
| 91 | MP0002269_muscular_atrophy | 0.79578199 |
| 92 | MP0003690_abnormal_glial_cell | 0.79266334 |
| 93 | MP0003186_abnormal_redox_activity | 0.78609089 |
| 94 | MP0003953_abnormal_hormone_level | 0.78352962 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.78314117 |
| 96 | MP0009764_decreased_sensitivity_to | 0.77251394 |
| 97 | MP0002933_joint_inflammation | 0.76815007 |
| 98 | MP0000747_muscle_weakness | 0.75659700 |
| 99 | MP0001614_abnormal_blood_vessel | 0.75549703 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.75398023 |
| 101 | MP0002925_abnormal_cardiovascular_devel | 0.75028354 |
| 102 | MP0002733_abnormal_thermal_nociception | 0.74483814 |
| 103 | MP0001661_extended_life_span | 0.71845774 |
| 104 | MP0003879_abnormal_hair_cell | 0.71699015 |
| 105 | MP0005409_darkened_coat_color | 0.70489782 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.70403745 |
| 107 | MP0004924_abnormal_behavior | 0.70215316 |
| 108 | MP0005386_behavior/neurological_phenoty | 0.70215316 |
| 109 | MP0005365_abnormal_bile_salt | 0.69338584 |
| 110 | MP0003300_gastrointestinal_ulcer | 0.68960817 |
| 111 | MP0001440_abnormal_grooming_behavior | 0.68144678 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.66930822 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.66930822 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.66309454 |
| 115 | MP0009278_abnormal_bone_marrow | 0.66131426 |
| 116 | MP0009785_altered_susceptibility_to | 0.65987586 |
| 117 | MP0005275_abnormal_skin_tensile | 0.64982821 |
| 118 | MP0005332_abnormal_amino_acid | 0.64542916 |
| 119 | MP0008004_abnormal_stomach_pH | 0.64449541 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.64268837 |
| 121 | MP0005164_abnormal_response_to | 0.63994218 |
| 122 | MP0005645_abnormal_hypothalamus_physiol | 0.63180557 |
| 123 | MP0004043_abnormal_pH_regulation | 0.63012640 |
| 124 | MP0002133_abnormal_respiratory_system | 0.61413641 |
| 125 | MP0005388_respiratory_system_phenotype | 0.61413641 |
| 126 | MP0003136_yellow_coat_color | 0.60930175 |
| 127 | MP0002970_abnormal_white_adipose | 0.60688121 |
| 128 | MP0001188_hyperpigmentation | 0.60641186 |
| 129 | MP0003195_calcinosis | 0.60209760 |
| 130 | MP0000372_irregular_coat_pigmentation | 0.59782241 |
| 131 | MP0005646_abnormal_pituitary_gland | 0.59590547 |
| 132 | MP0002272_abnormal_nervous_system | 0.59476176 |
| 133 | MP0004885_abnormal_endolymph | 0.58463200 |
| 134 | MP0001968_abnormal_touch/_nociception | 0.58386908 |
| 135 | MP0001958_emphysema | 0.57761934 |
| 136 | MP0009763_increased_sensitivity_to | 0.57368575 |
| 137 | MP0002006_tumorigenesis | 0.57192376 |
| 138 | MP0003567_abnormal_fetal_cardiomyocyte | 0.55157024 |
| 139 | MP0000609_abnormal_liver_physiology | 0.54384632 |
| 140 | MP0003252_abnormal_bile_duct | 0.50057197 |
| 141 | MP0002638_abnormal_pupillary_reflex | 0.49076471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ventricular tachycardia (HP:0004756) | 5.89971088 |
| 2 | Sudden death (HP:0001699) | 5.54643443 |
| 3 | Atrial fibrillation (HP:0005110) | 5.38541800 |
| 4 | Muscle fiber splitting (HP:0003555) | 4.92860557 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 4.89808012 |
| 6 | Supraventricular arrhythmia (HP:0005115) | 4.85979948 |
| 7 | Lipoatrophy (HP:0100578) | 4.85556960 |
| 8 | Supraventricular tachycardia (HP:0004755) | 4.69174602 |
| 9 | Hypoglycemic coma (HP:0001325) | 4.19388405 |
| 10 | Increased connective tissue (HP:0009025) | 4.13916379 |
| 11 | Myoglobinuria (HP:0002913) | 3.97466663 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.93524020 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 3.80007568 |
| 14 | Dilated cardiomyopathy (HP:0001644) | 3.78312861 |
| 15 | Palpitations (HP:0001962) | 3.73668042 |
| 16 | Prolonged QT interval (HP:0001657) | 3.67672264 |
| 17 | Syncope (HP:0001279) | 3.57518486 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 3.53695680 |
| 19 | Subaortic stenosis (HP:0001682) | 3.46099387 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.46099387 |
| 21 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.43359665 |
| 22 | Exercise-induced myalgia (HP:0003738) | 3.38160169 |
| 23 | Difficulty running (HP:0009046) | 3.37357230 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27826145 |
| 25 | Rhabdomyolysis (HP:0003201) | 3.21150214 |
| 26 | Hyperglycinuria (HP:0003108) | 3.06709778 |
| 27 | Dicarboxylic aciduria (HP:0003215) | 3.06193239 |
| 28 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.06193239 |
| 29 | Frequent falls (HP:0002359) | 3.05888604 |
| 30 | Polycythemia (HP:0001901) | 3.00867927 |
| 31 | Decreased circulating renin level (HP:0003351) | 3.00642623 |
| 32 | Type 1 muscle fiber predominance (HP:0003803) | 3.00510902 |
| 33 | Ketoacidosis (HP:0001993) | 2.97566881 |
| 34 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.94767348 |
| 35 | Muscle fiber inclusion bodies (HP:0100299) | 2.92965787 |
| 36 | Abnormality of the calf musculature (HP:0001430) | 2.91513221 |
| 37 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.86666540 |
| 38 | Oligomenorrhea (HP:0000876) | 2.86497345 |
| 39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.85850498 |
| 40 | Atrioventricular block (HP:0001678) | 2.85394560 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.84784325 |
| 42 | Renal cortical cysts (HP:0000803) | 2.82052463 |
| 43 | Neck muscle weakness (HP:0000467) | 2.80378619 |
| 44 | Broad metatarsal (HP:0001783) | 2.79853361 |
| 45 | Tetraparesis (HP:0002273) | 2.78450914 |
| 46 | Heart block (HP:0012722) | 2.77476469 |
| 47 | Acanthosis nigricans (HP:0000956) | 2.77456190 |
| 48 | Abnormal eating behavior (HP:0100738) | 2.76838181 |
| 49 | Prominent supraorbital ridges (HP:0000336) | 2.76519356 |
| 50 | Hypertriglyceridemia (HP:0002155) | 2.72523325 |
| 51 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.70999347 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.70901080 |
| 53 | Rimmed vacuoles (HP:0003805) | 2.67842696 |
| 54 | EMG: myopathic abnormalities (HP:0003458) | 2.67766708 |
| 55 | Exercise-induced muscle cramps (HP:0003710) | 2.66497503 |
| 56 | Bundle branch block (HP:0011710) | 2.63118591 |
| 57 | Nausea (HP:0002018) | 2.62549677 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.61427317 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.60344950 |
| 60 | Nemaline bodies (HP:0003798) | 2.58815872 |
| 61 | Abnormal EKG (HP:0003115) | 2.58494542 |
| 62 | Congenital stationary night blindness (HP:0007642) | 2.56702253 |
| 63 | Ventricular arrhythmia (HP:0004308) | 2.56475479 |
| 64 | Hepatic necrosis (HP:0002605) | 2.55920955 |
| 65 | Abnormal atrioventricular conduction (HP:0005150) | 2.55585121 |
| 66 | Bone cyst (HP:0012062) | 2.55199920 |
| 67 | Pulmonary artery stenosis (HP:0004415) | 2.55125051 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.53776358 |
| 69 | Esophageal varix (HP:0002040) | 2.52722175 |
| 70 | Abnormality of the ischium (HP:0003174) | 2.51696977 |
| 71 | Congenital, generalized hypertrichosis (HP:0004540) | 2.51385882 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.50999776 |
| 73 | Facial diplegia (HP:0001349) | 2.50879736 |
| 74 | Adactyly (HP:0009776) | 2.49798923 |
| 75 | Myotonia (HP:0002486) | 2.44764533 |
| 76 | Large hands (HP:0001176) | 2.43767500 |
| 77 | Pigmentary retinal degeneration (HP:0001146) | 2.41540629 |
| 78 | Tachypnea (HP:0002789) | 2.39448711 |
| 79 | Polyphagia (HP:0002591) | 2.38473840 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.37786772 |
| 81 | Abnormality of the renal cortex (HP:0011035) | 2.37443592 |
| 82 | Areflexia of lower limbs (HP:0002522) | 2.36882145 |
| 83 | Epidermoid cyst (HP:0200040) | 2.36324315 |
| 84 | Aplasia cutis congenita (HP:0001057) | 2.34558681 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.33350985 |
| 86 | Cerebral palsy (HP:0100021) | 2.33321472 |
| 87 | Abnormal hemoglobin (HP:0011902) | 2.33003213 |
| 88 | Hypoglycemic seizures (HP:0002173) | 2.32504594 |
| 89 | Toxemia of pregnancy (HP:0100603) | 2.31458077 |
| 90 | Hyperglycemia (HP:0003074) | 2.30099881 |
| 91 | Large for gestational age (HP:0001520) | 2.30078907 |
| 92 | Distal lower limb muscle weakness (HP:0009053) | 2.30008763 |
| 93 | Lymphangioma (HP:0100764) | 2.29049983 |
| 94 | Duplicated collecting system (HP:0000081) | 2.28391275 |
| 95 | Broad-based gait (HP:0002136) | 2.27575767 |
| 96 | Growth hormone excess (HP:0000845) | 2.24764004 |
| 97 | Neonatal death (HP:0003811) | 2.24194894 |
| 98 | Ketosis (HP:0001946) | 2.20246984 |
| 99 | Insulin resistance (HP:0000855) | 2.18420568 |
| 100 | Abnormality of the renal collecting system (HP:0004742) | 2.17465792 |
| 101 | Hyperventilation (HP:0002883) | 2.17231708 |
| 102 | Hypoalphalipoproteinemia (HP:0003233) | 2.17042666 |
| 103 | Pancreatic cysts (HP:0001737) | 2.16763648 |
| 104 | Abnormality of glycine metabolism (HP:0010895) | 2.16416536 |
| 105 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.16416536 |
| 106 | Testicular atrophy (HP:0000029) | 2.14111613 |
| 107 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.13308968 |
| 108 | Impulsivity (HP:0100710) | 2.12933957 |
| 109 | Pancreatic fibrosis (HP:0100732) | 2.12252829 |
| 110 | Nephronophthisis (HP:0000090) | 2.09493104 |
| 111 | Abnormality of alanine metabolism (HP:0010916) | 2.07452822 |
| 112 | Hyperalaninemia (HP:0003348) | 2.07452822 |
| 113 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.07452822 |
| 114 | Molar tooth sign on MRI (HP:0002419) | 2.06423817 |
| 115 | Abnormality of midbrain morphology (HP:0002418) | 2.06423817 |
| 116 | Polydipsia (HP:0001959) | 2.05649286 |
| 117 | Abnormal drinking behavior (HP:0030082) | 2.05649286 |
| 118 | Inability to walk (HP:0002540) | 2.03952235 |
| 119 | Nonimmune hydrops fetalis (HP:0001790) | 2.03556646 |
| 120 | Porencephaly (HP:0002132) | 2.03350621 |
| 121 | Portal hypertension (HP:0001409) | 2.03223175 |
| 122 | Left ventricular hypertrophy (HP:0001712) | 2.01194373 |
| 123 | Gowers sign (HP:0003391) | 2.01139604 |
| 124 | Increased serum pyruvate (HP:0003542) | 1.99749775 |
| 125 | Hyperammonemia (HP:0001987) | 1.99341745 |
| 126 | Accelerated skeletal maturation (HP:0005616) | 1.96673653 |
| 127 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95356027 |
| 128 | Spontaneous hematomas (HP:0007420) | 1.95108094 |
| 129 | Cerebral aneurysm (HP:0004944) | 1.94146976 |
| 130 | Palmoplantar keratoderma (HP:0000982) | 1.94087531 |
| 131 | Ileus (HP:0002595) | 1.93100006 |
| 132 | Ventricular fibrillation (HP:0001663) | 1.92945349 |
| 133 | Skin nodule (HP:0200036) | 1.92691806 |
| 134 | Complement deficiency (HP:0004431) | 1.90863034 |
| 135 | EMG: neuropathic changes (HP:0003445) | 1.90704243 |
| 136 | Abnormality of the renal medulla (HP:0100957) | 1.90330175 |
| 137 | Type II lissencephaly (HP:0007260) | 1.89427516 |
| 138 | Prenatal maternal abnormality (HP:0002686) | 1.88932637 |
| 139 | Hyperkalemia (HP:0002153) | 1.88429369 |
| 140 | Abnormality of the hepatic vasculature (HP:0006707) | 1.87565007 |
| 141 | Skull defect (HP:0001362) | 1.86233334 |
| 142 | Proximal tubulopathy (HP:0000114) | 1.85849470 |
| 143 | Mesangial abnormality (HP:0001966) | 1.85567317 |
| 144 | Infantile muscular hypotonia (HP:0008947) | 1.83958449 |
| 145 | Ulnar claw (HP:0001178) | 1.82018263 |
| 146 | Difficulty walking (HP:0002355) | 1.80892482 |
| 147 | True hermaphroditism (HP:0010459) | 1.77671627 |
| 148 | Abnormality of glycolysis (HP:0004366) | 1.77167970 |
| 149 | Cystic liver disease (HP:0006706) | 1.76505599 |
| 150 | Long foot (HP:0001833) | 1.75950899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 7.74266982 |
| 2 | KDR | 5.91141142 |
| 3 | INSRR | 2.98181133 |
| 4 | MYLK | 2.67197828 |
| 5 | TGFBR2 | 2.49120381 |
| 6 | ZAK | 2.46968689 |
| 7 | TTN | 2.40990490 |
| 8 | PDK2 | 2.16631056 |
| 9 | PDK4 | 2.06946517 |
| 10 | PDK3 | 2.06946517 |
| 11 | BCKDK | 2.06020051 |
| 12 | CAMK1D | 1.97885746 |
| 13 | MARK1 | 1.97738152 |
| 14 | OBSCN | 1.95597981 |
| 15 | RIPK1 | 1.92096822 |
| 16 | IRAK3 | 1.85832165 |
| 17 | ADRBK2 | 1.81525247 |
| 18 | DMPK | 1.75278281 |
| 19 | LMTK2 | 1.74446492 |
| 20 | WNK4 | 1.71842694 |
| 21 | PIK3CA | 1.66967673 |
| 22 | FGFR3 | 1.62677496 |
| 23 | MAPK13 | 1.60300866 |
| 24 | NTRK3 | 1.59920714 |
| 25 | DAPK2 | 1.49381264 |
| 26 | CAMKK2 | 1.40026101 |
| 27 | TGFBR1 | 1.35855924 |
| 28 | PHKG2 | 1.35551874 |
| 29 | PHKG1 | 1.35551874 |
| 30 | ADRBK1 | 1.33991483 |
| 31 | PRKAA2 | 1.33534272 |
| 32 | GRK5 | 1.32623433 |
| 33 | MAP4K2 | 1.29250673 |
| 34 | PKN1 | 1.28823921 |
| 35 | SIK1 | 1.24426543 |
| 36 | CAMK1G | 1.22284741 |
| 37 | MAPK12 | 1.16703245 |
| 38 | TAOK3 | 1.15805715 |
| 39 | TEC | 1.12884858 |
| 40 | MAP2K1 | 1.10331776 |
| 41 | PINK1 | 1.10243381 |
| 42 | MAPK15 | 1.09562909 |
| 43 | NME1 | 1.09267118 |
| 44 | NEK9 | 1.06605631 |
| 45 | WNK3 | 1.06246052 |
| 46 | PAK3 | 1.06000318 |
| 47 | EEF2K | 1.04539049 |
| 48 | TRIB3 | 1.03503002 |
| 49 | IRAK4 | 1.02209304 |
| 50 | MAP3K4 | 1.01318175 |
| 51 | PRKG1 | 1.01062050 |
| 52 | PTK2B | 1.01039076 |
| 53 | JAK1 | 0.99501300 |
| 54 | TNIK | 0.99243883 |
| 55 | PRKD1 | 0.92828462 |
| 56 | JAK3 | 0.92421649 |
| 57 | TRPM7 | 0.91450216 |
| 58 | MAP2K3 | 0.90012422 |
| 59 | TLK1 | 0.87897889 |
| 60 | STK24 | 0.87806763 |
| 61 | MAP3K14 | 0.85551725 |
| 62 | DDR2 | 0.85549146 |
| 63 | MAP2K6 | 0.84194291 |
| 64 | PRKACA | 0.82151882 |
| 65 | EPHB2 | 0.80386849 |
| 66 | FRK | 0.79089036 |
| 67 | RIPK4 | 0.77928149 |
| 68 | GRK7 | 0.77454365 |
| 69 | MUSK | 0.77094550 |
| 70 | MAPK7 | 0.76539517 |
| 71 | CAMK4 | 0.75155230 |
| 72 | PRKAA1 | 0.72424774 |
| 73 | MAPKAPK5 | 0.69418151 |
| 74 | CDK9 | 0.66579382 |
| 75 | MAP2K4 | 0.65189704 |
| 76 | TNK2 | 0.64640205 |
| 77 | PKN2 | 0.63686699 |
| 78 | FLT3 | 0.62781194 |
| 79 | CAMK2A | 0.61763678 |
| 80 | RPS6KA3 | 0.61133835 |
| 81 | PRKCH | 0.61100557 |
| 82 | GRK1 | 0.59861974 |
| 83 | CSK | 0.59443371 |
| 84 | PRKG2 | 0.58765631 |
| 85 | FGFR4 | 0.58495191 |
| 86 | STK11 | 0.57679060 |
| 87 | KIT | 0.57511385 |
| 88 | SGK2 | 0.57106620 |
| 89 | FER | 0.56270932 |
| 90 | MAP3K3 | 0.56228450 |
| 91 | CAMK1 | 0.55806846 |
| 92 | PIK3CG | 0.55721231 |
| 93 | TYRO3 | 0.53588191 |
| 94 | EIF2AK2 | 0.53395719 |
| 95 | IGF1R | 0.52876666 |
| 96 | MAPK3 | 0.51357847 |
| 97 | EPHB1 | 0.51066170 |
| 98 | PRKCE | 0.50539218 |
| 99 | PDPK1 | 0.50124902 |
| 100 | AKT3 | 0.49664146 |
| 101 | MARK3 | 0.48311588 |
| 102 | SGK3 | 0.47609727 |
| 103 | MAP3K7 | 0.47527806 |
| 104 | BMPR1B | 0.47354908 |
| 105 | ABL2 | 0.46907280 |
| 106 | MAPKAPK3 | 0.45462611 |
| 107 | STK39 | 0.45335967 |
| 108 | AKT2 | 0.43805122 |
| 109 | MARK2 | 0.43077353 |
| 110 | JAK2 | 0.42963915 |
| 111 | MKNK2 | 0.42124621 |
| 112 | EPHA3 | 0.41974480 |
| 113 | BCR | 0.40059734 |
| 114 | IRAK1 | 0.39677388 |
| 115 | LATS1 | 0.39594186 |
| 116 | ERN1 | 0.37763983 |
| 117 | STK4 | 0.37160613 |
| 118 | TBK1 | 0.35167501 |
| 119 | PDK1 | 0.34695619 |
| 120 | PRKCA | 0.34552928 |
| 121 | PRKACG | 0.34193030 |
| 122 | PDGFRA | 0.33917100 |
| 123 | CASK | 0.33668761 |
| 124 | HIPK2 | 0.33209083 |
| 125 | OXSR1 | 0.32901559 |
| 126 | BRSK2 | 0.32882728 |
| 127 | SIK3 | 0.31801821 |
| 128 | MAPK1 | 0.31662065 |
| 129 | SGK1 | 0.31521468 |
| 130 | PRKCG | 0.31455518 |
| 131 | ABL1 | 0.30943689 |
| 132 | PRKACB | 0.30237719 |
| 133 | CAMK2D | 0.29622538 |
| 134 | MAPK4 | 0.29058578 |
| 135 | TXK | 0.28550309 |
| 136 | CDC42BPA | 0.28249110 |
| 137 | NLK | 0.27557186 |
| 138 | MAP3K5 | 0.27527158 |
| 139 | FGFR2 | 0.27108563 |
| 140 | ILK | 0.26918020 |
| 141 | STK38L | 0.26898634 |
| 142 | TYK2 | 0.26865869 |
| 143 | GSK3A | 0.26587935 |
| 144 | MAP3K6 | 0.26394932 |
| 145 | ROCK1 | 0.25979099 |
| 146 | NUAK1 | 0.25571183 |
| 147 | CDK8 | 0.25477159 |
| 148 | PRKCQ | 0.25202170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.95996787 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.30645349 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.64538465 |
| 4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.18973330 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.12597494 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.11904700 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.07826944 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.51470881 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.50134925 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.40004167 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.30870231 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94095885 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.91377659 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.91027912 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.87629340 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.69547930 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68819956 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65767867 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64598977 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62839193 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57155484 |
| 22 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.56147289 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.55682387 |
| 24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.55283744 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.48077071 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.41746679 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.39516799 |
| 28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.39484689 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37361085 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36323578 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.31159317 |
| 32 | Morphine addiction_Homo sapiens_hsa05032 | 1.30141751 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.27001441 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21409776 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 1.17329556 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17016815 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 1.16920908 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.14506482 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14445034 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12249433 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.10336578 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10209306 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07598726 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.06382277 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03511981 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01597755 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01004681 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.00505123 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99864032 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99841417 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95216880 |
| 52 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.94900306 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.93943228 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.93691974 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92989774 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 0.92900719 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.92582038 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90959977 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89946560 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89857477 |
| 61 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87353293 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84574264 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83668962 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.81358319 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81333802 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.80687608 |
| 67 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80431150 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75395554 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74203847 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74087167 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73452475 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72543506 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72012405 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71132357 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.69641570 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67337180 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67177774 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66089339 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65836576 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64749969 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64603248 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63964205 |
| 83 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63368418 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63029378 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62964349 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.62469520 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61484004 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60572669 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60370941 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59958727 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59266653 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58546677 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58262382 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56739909 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55285168 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.55060922 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.54464481 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54371729 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54006505 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52108732 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.51573419 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50383963 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49964577 |
| 104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49761553 |
| 105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48747065 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47465678 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47208901 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46963448 |
| 109 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46001610 |
| 110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45893465 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44544564 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44382404 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44288308 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.43550110 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42830041 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42305192 |
| 117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42133889 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41087547 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.40774058 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39271314 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36895791 |
| 122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35920895 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35901966 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35658096 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34856239 |
| 126 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.34487017 |
| 127 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34332610 |
| 128 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34076183 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33800510 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33762406 |
| 131 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.32612193 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31669925 |
| 133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30147702 |
| 134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.30020971 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.29853611 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23974299 |
| 137 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23463547 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23292904 |
| 139 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22446413 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.21633700 |
| 141 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19825746 |
| 142 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.19284970 |
| 143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18542743 |
| 144 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.18526263 |

